{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:07:15Z","timestamp":1756897635700},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW Fortschr Med"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s15006-024-4105-y","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T23:02:56Z","timestamp":1723071776000},"page":"9-15","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Die katecholaminerge polymorphe ventrikul\u00e4re Tachykardie (CPVT)","Catecholaminergic polymorphic ventricular tachycardia (CPVT): an insidious disease that can often lead to sudden cardiac death in young people"],"prefix":"10.1007","volume":"166","author":[{"given":"Christoph","family":"Marschall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Diebold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"4105_CR2408","doi-asserted-by":"crossref","unstructured":"Kotta M-C et al. Cardiac genetic investigation of sudden infant and early childhood death: a study from victims to families. J Am Heart Assoc 2023;12(17):e029100","DOI":"10.1161\/JAHA.122.029100"},{"key":"4105_CR2412","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-J\u00e1imez J et al. Diagnostic approach to unexplained cardiac arrest (from the FIVI-Gen Study). Am J Cardiol 2015;116(6):894-899","DOI":"10.1016\/j.amjcard.2015.06.030"},{"key":"4105_CR2416","unstructured":"European Society of Cardiology. ESC-Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Version 2022"},{"key":"4105_CR2420","doi-asserted-by":"crossref","unstructured":"Roston T et al. The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry. Europace 2018;20:541-547","DOI":"10.1093\/europace\/euw389"},{"key":"4105_CR2424","doi-asserted-by":"crossref","unstructured":"Priori SG et al. Precision medicine in catecholaminergic polymorphic ventrivular tachycardia: JACC Focus Seminar 5\/5. J Am Coll Cardiol 2021;77(20):2592-2612","DOI":"10.1016\/j.jacc.2020.12.073"},{"key":"4105_CR2432","doi-asserted-by":"crossref","unstructured":"Clemens DJ et al. International Triadin Knockout Syndrome Registry. Circ Genom Precis Med 2019;12(2):e002419","DOI":"10.1161\/CIRCGEN.118.002419"},{"key":"4105_CR2436","doi-asserted-by":"crossref","unstructured":"Josephs KS et al. Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions. Genome Med 2023;15:86","DOI":"10.1186\/s13073-023-01246-8"},{"key":"4105_CR2440","doi-asserted-by":"crossref","unstructured":"Wilde AAM et al. European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. J Arrhythm 2022;38(4):491-553","DOI":"10.1002\/joa3.12717"},{"key":"4105_CR2444","doi-asserted-by":"crossref","unstructured":"Moscu-Gregor A et al. Novel variants in TECRL cause recessive inherited CPVT type 3 with severe and variable clinical symptoms. J Cardiovasc Electrophysiol 2020;31(6):1527-1535","DOI":"10.1111\/jce.14446"},{"key":"4105_CR2448","unstructured":"Ellard S et al. ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2020. https:\/\/www.acgs.uk.com\/media\/11631\/uk-practice-guidelines-for-variant-classification-v4-01-2020.pdf"},{"key":"4105_CR2452","doi-asserted-by":"crossref","unstructured":"K\u00f6nemann H et al. Management of ventricular arrhythmias worldwide: comparison of the latest ESC, AHA\/ACC\/HRS, and CCS\/CHRS guidelines. JACC Clin Electrophysiol 2023;9(5):715-728","DOI":"10.1016\/j.jacep.2022.12.008"},{"key":"4105_CR2456","doi-asserted-by":"crossref","unstructured":"Peltenburg PJ et al. An international multicenter cohort study on \u03b2-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia. Circulation 2022,145(5):333-344","DOI":"10.1161\/CIRCULATIONAHA.121.056018"},{"key":"4105_CR2428","doi-asserted-by":"crossref","unstructured":"Zhong X et al. Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death. Biosci Rep 2021;41(4):BSR20210209","DOI":"10.1042\/BSR20210209"},{"key":"4105_CR2463","doi-asserted-by":"crossref","unstructured":"Bezzerides VJ et al. Gene therapy for inherited arrhythmias. Cardiovasc Res 2020;116:1635-1650","DOI":"10.1093\/cvr\/cvaa107"},{"key":"4105_CR2467","doi-asserted-by":"crossref","unstructured":"Bongianino R, Priori SG.Gene therapy to treat cardiac arrhythmias. Nat Rev Cardiol 2015;12(9):531-546","DOI":"10.1038\/nrcardio.2015.61"},{"key":"4105_CR2471","doi-asserted-by":"crossref","unstructured":"Lodola F et al. Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia. Cell Death Dis 2016;7(10):e2393","DOI":"10.1038\/cddis.2016.304"},{"key":"4105_CR2475","doi-asserted-by":"crossref","unstructured":"Yamaguchi N et al. CRISPR\/Cas9 gene editing of RYR2 in human iPSC-derived cardiomyocytes to probe Ca2+ signaling aberrancies of CPVT arrhythmogenesis. In: Ishikawa K (Hrsg). Cardiac Gene Therapy. Methods in Molecular Biology, vol 2573. Humana, New York, NY 2022. https:\/\/doi.org\/10.1007\/978-1-0716-2707-5_4","DOI":"10.1007\/978-1-0716-2707-5_4"},{"key":"4105_CR2479","doi-asserted-by":"crossref","unstructured":"Dulhunty AF. Molecular changes in the cardiac RyR2 with catecholaminergic polymorphic ventricular tachycardia (CPVT). Front Physiol 2022;13:830367","DOI":"10.3389\/fphys.2022.830367"},{"key":"4105_CR2483","doi-asserted-by":"crossref","unstructured":"Pan X et al. In vivo Ryr2 editing corrects catecholaminergic polymorphic ventricular tachycardia. Circ Res 2018;123(8):953-963","DOI":"10.1161\/CIRCRESAHA.118.313369"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-024-4105-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-024-4105-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-024-4105-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T23:04:36Z","timestamp":1723071876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-024-4105-y"}},"subtitle":["Eine t\u00fcckische Erkrankung, die bei jungen Menschen zum pl\u00f6tzlichen Herztod f\u00fchren kann"],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":19,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["4105"],"URL":"https:\/\/doi.org\/10.1007\/s15006-024-4105-y","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"8 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Die Autorinnen und der Autor geben an, dass kein Interessenkonflikt im Zusammenhang mit diesem Beitrag vorliegt.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}